AVITA Medical, Inc.
RCEL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $64 | $50 | $34 | $33 |
| % Growth | 28.1% | 45.7% | 4.2% | – |
| Cost of Goods Sold | $9 | $8 | $6 | $6 |
| Gross Profit | $55 | $42 | $28 | $27 |
| % Margin | 85.8% | 84.5% | 82.4% | 81.5% |
| R&D Expenses | $20 | $21 | $14 | $16 |
| G&A Expenses | $33 | $28 | $23 | $21 |
| SG&A Expenses | $91 | $66 | $45 | $37 |
| Sales & Mktg Exp. | $58 | $37 | $22 | $16 |
| Other Operating Expenses | $0 | -$1 | -$3 | -$1 |
| Operating Expenses | $112 | $85 | $56 | $52 |
| Operating Income | -$57 | -$43 | -$28 | -$25 |
| % Margin | -88.1% | -85.1% | -79.9% | -76.1% |
| Other Income/Exp. Net | -$5 | $7 | $1 | $0 |
| Pre-Tax Income | -$62 | -$35 | -$27 | -$25 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$62 | -$35 | -$27 | -$25 |
| % Margin | -96.3% | -70.6% | -77.5% | -76.1% |
| EPS | -2.39 | -1.4 | -1.57 | -1.03 |
| % Growth | -70.7% | 10.8% | -52.4% | – |
| EPS Diluted | -2.39 | -1.4 | -1.57 | -1.03 |
| Weighted Avg Shares Out | 26 | 25 | 25 | 24 |
| Weighted Avg Shares Out Dil | 26 | 25 | 25 | 24 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $5 | $1 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$55 | -$34 | -$26 | -$24 |
| % Margin | -86.1% | -66.9% | -75.7% | -73.9% |